Pharmacogenomics Reporter GenomeWeb News Premium Content Existing subscribers login here. New to Pharmacogenomics Reporter? For a trial subscription click here.

FDA ‘Interested in Collaborating’ With
Personal Genomics Firms to Track AEs

[November 19, 2008]

By Turna Ray

In marketing ancestry and disease-predisposition genetic testing services directly to consumers, personal genomics companies are building large electronic databases of clinical and genomic information. The FDA believes these databases can help the agency track adverse reactions in a post-marketing setting.

Login | Subscribe